These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 12455202)

  • 1. Gemifloxacin. Factive, LB 20304, SB 265805.
    Drugs R D; 2002; 3(4):258-70. PubMed ID: 12455202
    [No Abstract]   [Full Text] [Related]  

  • 2. Gemifloxacin.
    Lowe MN; Lamb HM
    Drugs; 2000 May; 59(5):1137-47; discussion 1148. PubMed ID: 10852645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trovafloxacin: fourth generation fluoroquinolone.
    McNabb J; Nicolau D; Quintiliani R; Nightingale C
    Conn Med; 1998 Aug; 62(8):483-7. PubMed ID: 9753805
    [No Abstract]   [Full Text] [Related]  

  • 4. Trovafloxacin: in vitro activity, pharmacokinetics, and clinical experience. Introduction.
    Moellering RC
    Eur J Clin Microbiol Infect Dis; 1998 Jun; 17(6):403-4. PubMed ID: 9758282
    [No Abstract]   [Full Text] [Related]  

  • 5. Discovery of gemifloxacin (Factive, LB20304a): a quinolone of a new generation.
    Hong CY
    Farmaco; 2001; 56(1-2):41-4. PubMed ID: 11347965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quinolone generations: natural history or natural selection?
    Ball P
    J Antimicrob Chemother; 2000 Jul; 46 Suppl T1():17-24. PubMed ID: 10997595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical assessment of tosufloxacin tosilate.
    Kohno S
    J Infect Chemother; 2002 Mar; 8(1):19-27. PubMed ID: 11957115
    [No Abstract]   [Full Text] [Related]  

  • 8. Gemifloxacin (factive).
    Med Lett Drugs Ther; 2004 Sep; 46(1192):78-9. PubMed ID: 15452464
    [No Abstract]   [Full Text] [Related]  

  • 9. A new respiratory fluoroquinolone, oral gemifloxacin: a safety profile in context.
    Ball P; Mandell L; Patou G; Dankner W; Tillotson G
    Int J Antimicrob Agents; 2004 May; 23(5):421-9. PubMed ID: 15120718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of gemifloxacin in the treatment of community-acquired pneumonia: a randomized, double-blind comparison with trovafloxacin.
    Hammerschlag MR
    J Antimicrob Chemother; 2001 Nov; 48(5):735. PubMed ID: 11679567
    [No Abstract]   [Full Text] [Related]  

  • 11. A critical review of the fluoroquinolones: focus on respiratory infections.
    Zhanel GG; Ennis K; Vercaigne L; Walkty A; Gin AS; Embil J; Smith H; Hoban DJ
    Drugs; 2002; 62(1):13-59. PubMed ID: 11790155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of gemifloxacin on the normal human intestinal microflora.
    Barker PJ; Sheehan R; Teillol-Foo M; Palmgren AC; Nord CE
    J Chemother; 2001 Feb; 13(1):47-51. PubMed ID: 11233800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of typhoid fever with tosufloxacin].
    Ohnishi K; Murata M; Ajima I; Saku K; Nakamura A
    Kansenshogaku Zasshi; 1992 Sep; 66(9):1295-6. PubMed ID: 1431392
    [No Abstract]   [Full Text] [Related]  

  • 14. The fluoroquinolones after ciprofloxacin and ofloxacin.
    Hooper DC
    Curr Clin Top Infect Dis; 2000; 20():63-91. PubMed ID: 10943519
    [No Abstract]   [Full Text] [Related]  

  • 15. [Azithromycin in dentistry and oral surgery].
    Sasaki J
    Jpn J Antibiot; 2000 Jun; 53 Suppl B():117-24. PubMed ID: 12572095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapeutic prospects of new fluoroquinolones].
    Bryskier A; Chantot JF; Veyssier P
    Presse Med; 1985 Dec; 14(45):2291-4. PubMed ID: 2935814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trovafloxacin.
    Med Lett Drugs Ther; 1998 Mar; 40(1022):30-1. PubMed ID: 9529517
    [No Abstract]   [Full Text] [Related]  

  • 18. Gemifloxacin: a new fluoroquinolone approved for treatment of respiratory infections.
    Yoo BK; Triller DM; Yong CS; Lodise TP
    Ann Pharmacother; 2004; 38(7-8):1226-35. PubMed ID: 15187209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of gemifloxacin against Helicobacter pylori.
    Minehart HW; Chalker AF
    J Antimicrob Chemother; 2001 Mar; 47(3):360-1. PubMed ID: 11222574
    [No Abstract]   [Full Text] [Related]  

  • 20. In vitro susceptibility of Neisseria meningitidis isolates to gemifloxacin and ten other antimicrobial agents.
    Vázquez JA; Berrón S; Giménez MJ; de la Fuente L; Aguilar L
    Eur J Clin Microbiol Infect Dis; 2001 Feb; 20(2):150-1. PubMed ID: 11305475
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.